Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment - Wikidata - awgldk - TriplyDB

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

http://www.wikidata.org/entity/Q35165663

about

Caspase-1 inhibitors from an extremophilic fungus that target specific leukemia cell lines Regulation of epithelial-mesenchymal IL-1 signaling by PPARbeta/delta is essential for skin homeostasis and wound healing Pattern Recognition Receptors in Cancer Progression and Metastasis Interleukin 1β-A Potential Salivary Biomarker for Cancer Progression?Inflammasome in intestinal inflammation and cancer GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response.Cytokines, IBD, and colitis-associated cancer ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit Systematic review and meta-analysis on the association between IL-1B polymorphisms and cancer risk Gene expression profiles in peripheral blood mononuclear cells of Chinese nickel refinery workers with high exposures to nickel and control subjects Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.Tumor tissue protein signatures reflect histological grade of breast cancer Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancer Alterations of gene expression and protein synthesis in co-cultured adipose tissue-derived stem cells and squamous cell-carcinoma cells: consequences for clinical applications.Why not treat human cancer with interleukin-1 blockade?IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism Seminal plasma induces the expression of IL-1α in normal and neoplastic cervical cells via EP2/EGFR/PI3K/AKT pathway.Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls.Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling.Urinary interleukin-1β levels among gynecological patients.Preventive but not curative efficacy of celecoxib on bladder carcinogenesis in a rat model.A cytokine-mediated link between innate immunity, inflammation, and cancer.Alternative sources of omega-3 fats: can we find a sustainable substitute for fish?Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models.Association of interleukin 1 beta (IL-1β) polymorphism with mRNA expression and risk of non small cell lung cancer IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines.The role of cytokines in breast cancer development and progression Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition Ovarian epithelial-stromal interactions: role of interleukins 1 and 6.A multiplex panel of plasma markers of immunity and inflammation in classical kaposi sarcoma.A (99m)Tc-labeled dual-domain cytokine ligand for imaging of inflammation.Curcumin blocks interleukin-1 signaling in chondrosarcoma cells.Recent advances in colorectal cancer research: the microenvironment impact.Tributyltin alters secretion of interleukin 1 beta from human immune cells Pro-Inflammatory Cytokine IL-1β Up-Regulates CXC Chemokine Receptor 4 via Notch and ERK Signaling Pathways in Tongue Squamous Cell Carcinoma.Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway Computational Identification of Mechanistic Factors That Determine the Timing and Intensity of the Inflammatory Response.

P2860

Q24634265-205AA542-E36C-4233-B2E5-69C3D8AD9237 Q24643750-E3D2F87F-998A-4EE4-A403-40CEB6056ED0 Q26798034-50D5EB1F-6094-4B4E-BC4E-8DE849EF464C Q26798564-343CC0A4-047F-4F92-9ED3-0B9F28639161 Q27026882-9E390AAC-8CC1-4993-B119-DDB8796458A1 Q27322202-281FA648-A60D-444B-B3B5-9ADCBA2012E0 Q28080901-1932380D-58ED-49C2-85E5-E368C82051AD Q28242049-516099BE-222C-4066-ACFD-21C2C90840CE Q28383264-3E27044D-799C-4751-BC69-E23A97A4D6C3 Q28394091-969F8A78-2AD6-431B-A896-FE4A3B1E0A64 Q28547683-CEA55BBF-8BA2-41F5-8535-405A2714CFD0 Q30234827-2A7E8B79-4402-4E5D-A18D-D54FC8EE6C1E Q33365644-0C7A5373-AC30-4CC5-80B0-1FE3E34FD8D5 Q33673719-9B084D6F-ED88-4E4E-B03D-CD55E57BF1A8 Q33684911-A02AEE18-AA47-4ACA-A2EC-3EDD191ADB78 Q33827061-14350901-BAC5-4B16-853D-11AA1AAB3D0B Q33833871-2012F58A-839A-4338-8BDC-04C314D8A431 Q33992811-ED1D3666-45F3-46D2-B758-0A58E91FE3DA Q34079481-E15EBBDA-DD09-42A0-9825-BB55FB28D063 Q34199061-927B3BB3-1A7A-4185-B0F9-F46586AFAAB8 Q34485557-FD713016-0934-46B8-AC78-04F7786C5725 Q34577547-F2565526-A46F-45F9-9BD8-15055DCF95BF Q34584672-2EECD4DA-6B17-4116-A4CB-DB3A5EB311BD Q34591055-7A33AA26-2062-435A-A60A-E1C724E7ADB0 Q34625152-ABC087AC-F68F-415B-8737-1A936386A87B Q34650675-C42C57C6-BD80-4021-9546-C406761EBE1C Q34713778-40D6B114-2790-44B1-8D7B-C15A672F0B6F Q34878666-C9035396-7191-4FB0-AF98-4F083404DE85 Q34911427-B910EC17-0994-41D1-A35F-B1BD04B72E7B Q34920381-1B62DB4C-5F52-4968-89D4-E24DDD9D9AF5 Q34984217-6A0A3622-35A8-4C18-B3BB-32CBD6F15B7F Q35101318-470CC572-C2E1-464B-93C4-05110622A25D Q35102683-392966CD-4794-4B5A-AA6C-DE0005228666 Q35167359-03446E61-B86D-4F9D-B7E5-CBB84CD5BD6F Q35182021-33CCD34F-F9AA-4A84-9953-3254C3F917E6 Q35206650-FC526BB1-8294-474A-BAE1-FE3D6231A427 Q35582631-32000B76-BF63-421A-A900-BFF4AA5E841B Q35691912-774CFD52-F5E2-4264-A0B1-BB707EEB34E3 Q35748219-950F4503-A30C-4578-9350-622B5CCB095A Q35859983-A9BB5A6B-F6BD-4C68-840D-6F3DBBE9276D

P2860

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

http://www.wikidata.org/entity/Q35165663

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Interleukin-1 and cancer progr ...... utic agent in cancer treatment

@ast

Interleukin-1 and cancer progr ...... utic agent in cancer treatment

@en

type

label

Interleukin-1 and cancer progr ...... utic agent in cancer treatment

@ast

Interleukin-1 and cancer progr ...... utic agent in cancer treatment

@en

prefLabel

Interleukin-1 and cancer progr ...... utic agent in cancer treatment

@ast

Interleukin-1 and cancer progr ...... utic agent in cancer treatment

@en

P1433

Q35165663-DD0104B7-0565-44FC-9157-8D3C8B592040

P1476

Q35165663-712158C5-7FE7-44FF-A745-DC15252B4AF7

P2093

Q35165663-0754CE7F-BE3E-4D5F-B289-B74648A6D94C

Q35165663-4B586D5F-8E85-4304-BB56-E0920A68E15A

Q35165663-89F30D94-18F9-4FF8-A3FE-8B6CB4B6173F

Q35165663-F88C6EBF-885A-4908-84D0-66A8858B62AE

P2860

Q35165663-05B7E73B-6613-4939-B88A-64ED1B4914ED

Q35165663-0A71382C-BA1A-41EA-8426-EE7A43A04D26

Q35165663-116BC789-C9A7-479B-A71E-47D4E873178D

Q35165663-2D326508-7A9D-4252-9EED-EC38F8EF3BF6

Q35165663-3500B671-F9CD-43D6-BAF3-16F905B0C232

Q35165663-3626F109-DD53-4057-A16E-E3D0458D98AF

Q35165663-3B144D08-A4D8-4816-8678-F0E625A3FFF0

Q35165663-3D20453B-1AC6-4CDA-90E6-9D004D375B59

Q35165663-4B3054F7-D97C-4002-B6C8-2D96527866F4

Q35165663-4B60E048-3BC6-4618-9530-DAE9DB5BA7F0

P2888

Q35165663-DF468178-B1C6-47B5-9C13-52D861C1EBBD

P304

Q35165663-26FF43C7-7D25-401D-8BFD-FA099A88131B

P31

Q35165663-EECA0721-B734-4B62-9C42-25D23F84FF41

P356

Q35165663-D3405F32-0969-473E-A5ED-6D7A0C3FC785

P478

Q35165663-021920D7-3AD2-4E33-BFFB-E8C09E3E6501

P577

Q35165663-F54E0A45-334D-49A7-8E9E-845D66FFAA0F

P5875

Q35165663-B77E402C-593F-44FB-91E2-FAD26AB33508

P698

Q35165663-FF8A7ECD-3C90-4C99-800B-CC883C7543C9

P921

Q35165663-08833ff5-e4e7-4d36-9426-744730eb96a1

P932

Q35165663-FDA9DE65-257C-4CF9-83E8-E2C1BAB3495A

P356

P1433

Journal of Translational Medicine

P1476

Interleukin-1 and cancer progr ...... utic agent in cancer treatment

@en

P2093

Anne M Lewis

http://www.w3.org/2001/XMLSchema#string

H Richard Alexander

http://www.w3.org/2001/XMLSchema#string

Hui Xu

http://www.w3.org/2001/XMLSchema#string

Sheelu Varghese

http://www.w3.org/2001/XMLSchema#string

P2860

Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist

Inflammation and cancer: back to Virchow?

The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action

Cytokine traps: multi-component, high-affinity blockers of cytokine action

Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme

IL-1 receptor accessory protein is an essential component of the IL-1 receptor

Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock

IL-1 is required for tumor invasiveness and angiogenesis

Biologic basis for interleukin-1 in disease

Infections as a major preventable cause of human cancer.

P2888

P304

48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-4-48

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6700279

http://www.w3.org/2001/XMLSchema#string

P698

17096856

http://www.w3.org/2001/XMLSchema#string

P921

P932

1660548

http://www.w3.org/2001/XMLSchema#string